Citadel Advisors - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y904. A total of 3 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2016$119,000
+20.2%
37,800
+27.3%
0.00%
Q1 2016$99,000
+73.7%
29,700
+84.5%
0.00%
Q4 2015$57,000
+1.8%
16,100
+43.8%
0.00%
Q3 2015$56,000
-20.0%
11,200
+2.8%
0.00%
Q2 2015$70,000
-34.0%
10,900
-27.3%
0.00%
Q1 2015$106,000
-59.1%
15,000
-55.4%
0.00%
Q4 2014$259,000
+32.1%
33,600
+28.2%
0.00%
Q3 2014$196,000
+25.6%
26,200
+62.7%
0.00%
Q2 2014$156,000
+71.4%
16,100
+46.4%
0.00%
Q1 2014$91,000
-15.7%
11,000
-14.1%
0.00%
Q4 2013$108,000
+16.1%
12,800
+9.4%
0.00%
Q3 2013$93,000
+158.3%
11,700
+154.3%
0.00%
Q2 2013$36,0004,6000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 19,600$99,0000.00%
Citadel Advisors 11,200$56,0000.00%
SIMPLEX TRADING, LLC 54$00.00%
View complete list of PDL BIOPHARMA INC shareholders